Improving CarE for Community Acquired Pneumonia 1 (ICE-CAP2)
Condition:   Pneumonia Childhood Intervention:   Behavioral: Clinical Decision Support Sponsors:   Vanderbilt University Medical Center;   National Institute of Allergy and Infectious Diseases (NIAID);   University of Pittsburgh Medical Center Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 2) (OPAL-Aim 2)
Condition:   HIV/AIDS Interventions:   Behavioral: Healthy Living Intervention (HLI);   Behavioral: Standard of Care Sponsors:   University of California, San Francisco;   University of California, Berkeley;   Makerere University;   Infectious Diseases Research Collaboration, Uganda;   Kenya Medical Research Institute;   National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Evaluation of The Food Allergy Mastery Program
Condition:   Food Allergy in Children Intervention:   Behavioral: Food Allergy Mastery Program Sponsors:   Children's National Research Institute;   National Institute of Allergy and Infectious Diseases (NIAID);   Northwestern University;   Rhode Island Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIV
Condition:   HIV Interventions:   Biological: N332-GT5 gp140 (IM, Bolus);   Biological: N332-GT5 gp140 (IM, Fractioned);   Biological: N332-GT5 gp140 (SC, Bolus);   Biological: N332-GT5 gp140 (SC, Fractioned);   Biological: SMNP (IM, Bolus);   Biological: SMNP (IM, Fractioned);   Biological: SMNP (S C, Bolus);   Biological: SMNP (SC, Fractioned) Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institutes of Health (NIH);   Department of Health and Human Services Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Tocilizumab in Lung Transplantation
Condition:   Lung Transplant Interventions:   Drug: Tocilizumab;   Drug: Placebo for Tocilizumab Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Improving CarE for Community Acquired Pneumonia 1 (ICE-CAP2)
Condition:   Pneumonia Childhood Intervention:   Behavioral: Clinical Decision Support Sponsors:   Vanderbilt University Medical Center;   National Institute of Allergy and Infectious Diseases (NIAID);   University of Pittsburgh Medical Center Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Evaluation of The Food Allergy Mastery Program
Condition:   Food Allergy in Children Intervention:   Behavioral: Food Allergy Mastery Program Sponsors:   Children's National Research Institute;   National Institute of Allergy and Infectious Diseases (NIAID);   Northwestern University;   Rhode Island Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 2) (OPAL-Aim 2)
Condition:   HIV/AIDS Interventions:   Behavioral: Healthy Living Intervention (HLI);   Behavioral: Standard of Care Sponsors:   University of California, San Francisco;   University of California, Berkeley;   Makerere University;   Infectious Diseases Research Collaboration, Uganda;   Kenya Medical Research Institute;   National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Improving CarE for Community Acquired Pneumonia 1 (ICE-CAP2)
Condition:   Pneumonia Childhood Intervention:   Behavioral: Clinical Decision Support Sponsors:   Vanderbilt University Medical Center;   National Institute of Allergy and Infectious Diseases (NIAID);   University of Pittsburgh Medical Center Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIV
Condition:   HIV Interventions:   Biological: N332-GT5 gp140 (IM, Bolus);   Biological: N332-GT5 gp140 (IM, Fractioned);   Biological: N332-GT5 gp140 (SC, Bolus);   Biological: N332-GT5 gp140 (SC, Fractioned);   Biological: SMNP (IM, Bolus);   Biological: SMNP (IM, Fractioned);   Biological: SMNP (S C, Bolus);   Biological: SMNP (SC, Fractioned) Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institutes of Health (NIH);   Department of Health and Human Services Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Tocilizumab in Lung Transplantation
Condition:   Lung Transplant Interventions:   Drug: Tocilizumab;   Drug: Placebo for Tocilizumab Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Evaluation of The Food Allergy Mastery Program
Condition:   Food Allergy in Children Intervention:   Behavioral: Food Allergy Mastery Program Sponsors:   Children's National Research Institute;   National Institute of Allergy and Infectious Diseases (NIAID);   Northwestern University;   Rhode Island Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 2) (OPAL-Aim 2)
Condition:   HIV/AIDS Interventions:   Behavioral: Healthy Living Intervention (HLI);   Behavioral: Standard of Care Sponsors:   University of California, San Francisco;   University of California, Berkeley;   Makerere University;   Infectious Diseases Research Collaboration, Uganda;   Kenya Medical Research Institute;   National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIV
Condition:   HIV Interventions:   Biological: N332-GT5 gp140 (IM, Bolus);   Biological: N332-GT5 gp140 (IM, Fractioned);   Biological: N332-GT5 gp140 (SC, Bolus);   Biological: N332-GT5 gp140 (SC, Fractioned);   Biological: SMNP (IM, Bolus);   Biological: SMNP (IM, Fractioned);   Biological: SMNP (S C, Bolus);   Biological: SMNP (SC, Fractioned) Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institutes of Health (NIH);   Department of Health and Human Services Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Tocilizumab in Lung Transplantation
Condition:   Lung Transplant Interventions:   Drug: Tocilizumab;   Drug: Placebo for Tocilizumab Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials